Outcomes for extremely premature infants

Area of Science:

• Neonatalogy
• Perinatology
• Pediatric Critical Care

Background:

• Premature birth remains a leading cause of infant mortality and morbidity.
• Despite a recent decline in the US, the premature birth rate is approximately 11.39%, with human viability around 23-24 weeks gestation.
• Extremely premature infants (<28 weeks gestation) and extremely low birth weight infants (<1000 g) face significant mortality (30-50%) and morbidity (20-50%) risks.

Purpose of the Study:

• To review the advancements in neonatal intensive care for extremely premature infants.
• To highlight the persistent challenges and evolving strategies in managing extremely low birth weight infants.
• To emphasize the critical need for long-term follow-up and novel interventions.

Main Methods:

• Review of historical and recent advancements in neonatal care, including respiratory support, surfactant therapy, antenatal steroids, and oxygen saturation targets.
• Discussion of the impact of neonatal intensive care units and neurocritical care on outcomes.
• Examination of ongoing research into antioxidant and anti-inflammatory pathways.

Main Results:

• Introduction of continuous positive airway pressure, mechanical ventilation, and exogenous surfactant in the 1970s-1990s improved survival.
• Routine antenatal steroids in the late 1990s reduced neonatal mortality and morbidity.
• Current research on oxygen saturation targets (91-95%) may further improve outcomes, pending final data analysis.

Conclusions:

• Neonatal intensive care has significantly improved survival rates for premature infants.
• Extremely premature infants continue to require specialized care and long-term developmental monitoring.
• Future research focusing on organ protection, growth preservation, and anti-inflammatory/antioxidant strategies is crucial for improving long-term outcomes.